U.S. Gene Therapy Market


USD 2,450.00

* Required Fields

USD 2,450.00


Be the first to review this product

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

Table of Contents

U.S. Gene Therapy Market, Executive SummaryMarket OverviewIntroductionIndustry BackgroundSummary of the Major FindingsTrend Analysis and Competitive LandscapeTrend AnalysisCompetitive LandscapeU.S. Gene Therapy Market, Total Gene Therapy Market AnalysisOverview and DefinitionsMarket Overview & TechnologyDisease Features for Gene Therapy CandidatesAcronymsMarket Challenges - Drivers and RestraintsMarket ChallengesMarket DriversMarket RestraintsTotal Market Revenue Forecast & Competitive AnalysisMethodology & AssumptionsRevenue ForecastCompetitive AnalysisMarket Engineering Measurement AnalysisFive Forces of CompetitionMarket Engineering Awards for the Gene Therapy MarketIntroduction and OverviewBusiness Development StrategyEntrepreneurial CompanyTechnology Innovation and LeadershipU.S. Gene Therapy Market, Gene Therapy Delivery Market SegmentsIntroduction and OverviewTechnology Overview Delivery Methods & CharacteristicsRole of Viral Vectors in Gene TherapyOverview of Viral VectorsRetroviral VectorsRetroviral VectorsLentiviral VectorsCompanies With Retroviral Vector TechnologyAdenoviral and Adeno-Associated Viral VectorsAdenoviral Vector CharacteristicsAssessment of the Adenoviral Vector MarketAdeno-Associated Viral (AAV) VectorsCompanies With Adeno-Associated Vector TechnologyVaccinia VectorsUnderstanding Vaccinia VectorsCompanies With Vaccina Viral Vector TechnologyHerpes Simplex Virus (HSV) VectorsUnderstanding Herpes Simplex Viral VectorsCompanies With Herpes Simplex ViralRole of Non-Viral Delivery Methods in Gene TherapyOverviewCalcium Phosphate and DEAE DextranOverviewMarket AssessmentElectroporationOverviewMarket AssessmentLiposomesOverviewCompanies With Liposome TechnologyNaked Plasmid DNA InjectionOverviewCompanies With Naked DNA TechnologyMicroinjectionOverviewMarket AssessmentBallistic DNA InjectionOverviewCompanies With Ballistic DNA Injection TechnologyNovel Non-Viral Gene Therapy TechnologiesSynthetic Minichromosomes/Artificial ChromosomesGene Switching & Activation Technology Gene Targeting and Transposon Vector Gene TherapyGenetically-Modified BacteriaSpliceosome-Mediated Gene TherapyGlycomicsU.S. Gene Therapy Market, Key Gene Therapy Application Market SegmentsTotal MarketMarket OverviewMonogenic Disease Gene TherapyMonogenic Disease OverviewRevenue ForecastCancer Gene TherapyDisease OverviewMost Commonly Targeted CancersKey Market ParticipantsRevenue ForecastCardiovascular Gene TherapyDisease OverviewKey Market ParticipantsRevenue ForecastU.S. Gene Therapy Market, Decision Support DatabaseCancer IncidenceIncidence of Breast CancerIncidence of Bladder CancerIncidence of Colorectal CancerIncidence of Liver CancerIncidence of Lung CancerIncidence of Prostrate CancerIncidence of Stomach CancerOthersNumber of Specialized Medical PractitionersGovernment Investment in BiotechPrivate Investment in BiotechNumber of Biotech Companies

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.